Takao Fujisawa Selected Research

Respiratory Sounds (Crackle)

1/2022	Serum Eosinophilic Cationic Protein Is a Reliable Biomarker for Childhood Asthma.
1/2019	Biomarkers for Recurrent Wheezing and Asthma in Preschool Children.
5/2013	Eosinophil-derived neurotoxin levels at 3 months post-respiratory syncytial virus bronchiolitis are a predictive biomarker of recurrent wheezing.
5/2010	A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation.
11/2009	[Factors related to recurrent wheezing after hospitalization with RSV infection with the children who were aged three years old or younger: a questionnaire survey].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takao Fujisawa Research Topics

Disease

41	Asthma (Bronchial Asthma) 03/2024 - 02/2002
22	Inflammation (Inflammations) 03/2024 - 02/2002
19	Hypersensitivity (Allergy) 11/2023 - 11/2009
16	Neoplasms (Cancer) 04/2024 - 10/2016
9	Squamous Cell Carcinoma of Head and Neck 12/2023 - 01/2018
8	Atopic Dermatitis (Atopic Eczema) 11/2023 - 07/2002
7	Anaphylaxis (Anaphylactic Shock) 01/2023 - 02/2013
6	Food Hypersensitivity (Food Allergy) 02/2023 - 01/2012
6	Allergic Rhinitis 01/2020 - 01/2008
5	Respiratory Sounds (Crackle) 01/2022 - 11/2009
5	Airway Remodeling 01/2018 - 01/2005
5	Seasonal Allergic Rhinitis (Hay Fever) 06/2014 - 01/2008
4	Disease Progression 04/2024 - 01/2020
4	Milk Hypersensitivity (Milk Allergy) 01/2024 - 01/2020
4	Infections 01/2023 - 09/2012
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 01/2020
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 11/2012
4	Egg Hypersensitivity (Egg Allergy) 10/2021 - 01/2016
4	Bronchiolitis 05/2013 - 05/2010
3	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 01/2023
3	Nasopharyngeal Carcinoma 01/2022 - 12/2017
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2022 - 12/2017
3	Wheat Hypersensitivity (Wheat Allergy) 01/2021 - 06/2009
3	Pneumococcal Infections 11/2020 - 01/2018
2	Pain (Aches) 01/2023 - 09/2009
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 10/2021
2	Pneumonia (Pneumonitis) 01/2019 - 02/2016
2	Malnutrition (Nutritional Deficiencies) 01/2019 - 02/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 06/2016 - 05/2010
2	Bronchiectasis 06/2016 - 07/2010
2	Human Influenza (Influenza) 02/2016 - 09/2012

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2008
13	Immunoglobulin E (IgE)IBA 01/2023 - 09/2008
12	CytokinesIBA 02/2023 - 01/2005
10	Cetuximab (Erbitux)FDA Link 12/2023 - 01/2018
10	AllergensIBA 02/2023 - 01/2008
9	Proteins (Proteins, Gene)FDA Link 10/2023 - 02/2002
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 07/2010
7	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 01/2018
7	Eosinophil-Derived NeurotoxinIBA 01/2023 - 05/2010
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2022 - 07/2010
6	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 01/2020
6	NivolumabIBA 12/2023 - 01/2020
5	PlatinumIBA 01/2023 - 01/2018
5	VaccinesIBA 05/2022 - 03/2016
5	Interleukin-5 (Interleukin 5)IBA 04/2012 - 02/2002
4	Immune Checkpoint InhibitorsIBA 08/2023 - 12/2022
4	Ointments (Pastes)IBA 10/2022 - 12/2019
4	EmollientsIBA 10/2022 - 12/2019
4	Tacrolimus (Prograf)FDA LinkGeneric 10/2022 - 12/2019
4	montelukast (Singulair)FDA Link 11/2018 - 05/2010
4	ChemokinesIBA 07/2017 - 07/2002
4	tulobuterolIBA 03/2013 - 05/2012
3	lenvatinibIBA 11/2023 - 01/2023
3	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 04/2023 - 01/2013
3	Conjugate VaccinesIBA 01/2023 - 01/2018
3	Superoxide Dismutase-1IBA 01/2022 - 10/2015
3	AntigensIBA 10/2021 - 06/2009
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2008
3	AntibodiesIBA 01/2017 - 01/2011
3	Procaterol (Pro-Air)IBA 01/2017 - 02/2002
3	Catechin (Z 7300)IBA 06/2014 - 09/2009
3	TeaIBA 06/2014 - 09/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014 - 01/2008
2	Circulating Tumor DNAIBA 04/2024 - 12/2022
2	Monoclonal AntibodiesIBA 03/2024 - 11/2012
2	Serum AlbuminIBA 11/2023 - 02/2016
2	LipidsIBA 10/2023 - 08/2005
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2023 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2016
2	GlobulinsIBA 01/2023 - 01/2022
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2020
2	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 02/2002
2	dupilumabIBA 01/2023 - 10/2020
2	delgocitinibIBA 10/2022 - 10/2022
2	Milk Proteins (Milk Protein)IBA 05/2022 - 01/2020
2	COVID-19 VaccinesIBA 01/2021 - 01/2021
2	Contrast MediaIBA 10/2020 - 01/2020
2	Gemcitabine FDA Link 01/2020 - 12/2017
2	Budesonide (Pulmicort)FDA LinkGeneric 11/2018 - 01/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2012
2	Peptide Hydrolases (Proteases)FDA Link 07/2017 - 01/2008
2	Omalizumab (Xolair)FDA Link 01/2017 - 10/2015
2	Salmeterol Xinafoate (Serevent)FDA Link 07/2016 - 07/2010
2	Fluticasone (Cutivate)FDA LinkGeneric 07/2016 - 10/2015
2	gallocatechol (epigallocatechin)IBA 06/2014 - 01/2014
2	methyl gallateIBA 06/2014 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2014 - 08/2005
2	Superoxides (Superoxide)IBA 01/2013 - 01/2008
2	InterleukinsIBA 04/2012 - 02/2002

Therapy/Procedure

23	Therapeutics 04/2024 - 06/2009
11	Immunotherapy 01/2024 - 01/2008
6	Drug Therapy (Chemotherapy) 12/2023 - 12/2017
4	Precision Medicine 01/2023 - 11/2021
4	Chemoradiotherapy 01/2023 - 01/2018
3	Complementary Therapies (Alternative Medicine) 06/2014 - 01/2012
2	Induction Chemotherapy 01/2022 - 01/2020
2	Aftercare (After-Treatment) 07/2020 - 01/2018
2	Oral Administration 01/2020 - 01/2011